Tolerizing Agonist/Immunomodulator Loaded Liposomes for Long-Lived Immune Tolerance
SUMMARY More selective suppression of disease-related immune responses may reduce reliance on broad immunosuppression; this preclinical approach co-delivers a disease antigen, immunomodulatory drugs, and TLR agonists in liposomes to promote antigen-specific immune tolerance. The Unmet Need: Broad immunosuppression can suppress protective immunity alongside disease-related responses Current broad immunosuppressive approaches may… Read More